[{"address1": "4149 Liberty Canyon Road", "city": "Agoura Hills", "state": "CA", "zip": "91301", "country": "United States", "phone": "805 456 4393", "website": "https://www.acelyrin.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Acelyrin, Inc., a clinical biopharma company, focuses on identifying, acquiring, and accelerating the development and commercialization of transformative medicines. The company's lead product candidate is lonigutamab, a subcutaneously delivered monoclonal antibody targeting IGF-1R, which has completed Phase 2 clinical trial for the treatment of Thyroid Eye Disease (TED). Acelyrin, Inc. was incorporated in 2020 and is headquartered in Agoura Hills, California. As of May 21, 2025, Acelyrin, Inc. operates as a subsidiary of Alumis Inc.", "fullTimeEmployees": 83, "companyOfficers": [{"maxAge": 1, "name": "Ms. Mina  Kim J.D.", "age": 50, "title": "CEO & Director", "yearBorn": 1974, "fiscalYear": 2024, "totalPay": 906640, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Shephard  Mpofu M.D.", "age": 57, "title": "Chief Medical Officer", "yearBorn": 1967, "fiscalYear": 2024, "totalPay": 679645, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Tyler  Marciniak", "title": "Vice President of Investor Relations, Communications & Corporate Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. K. Amar Murugan J.D.", "age": 48, "title": "Chief Legal Officer", "yearBorn": 1976, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Kelly  Chow", "title": "Chief People Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Kenneth A. Lock", "age": 50, "title": "Chief Commercial Officer", "yearBorn": 1974, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Patricia A. Turney", "age": 57, "title": "Chief Technical Operations Officer", "yearBorn": 1967, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 9, "boardRisk": 4, "compensationRisk": 10, "shareHolderRightsRisk": 10, "overallRisk": 10, "governanceEpochDate": 1746057600, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 2.27, "open": 2.24, "dayLow": 2.27, "dayHigh": 2.27, "regularMarketPreviousClose": 2.27, "regularMarketOpen": 2.24, "regularMarketDayLow": 2.27, "regularMarketDayHigh": 2.27, "payoutRatio": 0.0, "beta": 1.088, "forwardPE": -1.1293533, "volume": 4059159, "regularMarketVolume": 4059159, "averageVolume": 986030, "averageVolume10days": 1352234, "averageDailyVolume10Day": 1352234, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "marketCap": 229165584, "fiftyTwoWeekLow": 1.845, "fiftyTwoWeekHigh": 7.25, "fiftyDayAverage": 2.3996, "twoHundredDayAverage": 3.548775, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -174359216, "profitMargins": 0.0, "floatShares": 68449604, "sharesOutstanding": 100954000, "sharesShort": 3568798, "sharesShortPriorMonth": 3649349, "sharesShortPreviousMonthDate": 1743379200, "dateShortInterest": 1745971200, "sharesPercentSharesOut": 0.0354, "heldPercentInsiders": 0.07148, "heldPercentInstitutions": 0.91977, "shortRatio": 3.8, "shortPercentOfFloat": 0.0385, "impliedSharesOutstanding": 100954000, "bookValue": 4.036, "priceToBook": 0.5624381, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1743379200, "netIncomeToCommon": -268516992, "trailingEps": -2.69, "forwardEps": -2.12, "enterpriseToEbitda": 0.646, "52WeekChange": -0.42964822, "SandP52WeekChange": 0.12748289, "exchange": "NMS", "quoteType": "EQUITY", "symbol": "SLRN", "underlyingSymbol": "SLRN", "shortName": "ACELYRIN, INC.", "longName": "Acelyrin, Inc.", "firstTradeDateEpochUtc": 1683293400, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "331b354b-7a4d-3b82-ac00-9819e1a01b9d", "messageBoardId": "finmb_698766339", "gmtOffSetMilliseconds": -14400000, "currentPrice": 2.27, "targetHighPrice": 8.0, "targetLowPrice": 8.0, "targetMeanPrice": 8.0, "targetMedianPrice": 8.0, "recommendationMean": 1.0, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 1, "totalCash": 410592000, "totalCashPerShare": 4.067, "ebitda": -270064000, "totalDebt": 7068000, "quickRatio": 17.811, "currentRatio": 18.431, "debtToEquity": 1.736, "returnOnAssets": -0.29822, "returnOnEquity": -0.51083, "freeCashflow": -174141632, "operatingCashflow": -285576992, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2025-06-28"}]